Task: Answer the multiple choice question.
Query: Which drug exhibits a 0.959\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) O=C(Nc1nnc(C2CCCCC2)s1)C1CC(=O)N(c2ccc(F)cc2)C1
b.) CC1=NN(C(=O)c2c(Br)cnn2C)C(O)(C(F)(F)F)C1
Answer: b. CC1=NN(C(=O)c2c(Br)cnn2C)C(O)(C(F)(F)F)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1=NN(C(=O)c2c(Br)cnn2C)C(O)(C(F)(F)F)C1
CC1=NN(C(=O)c2c(Br)cnn2C)C(O)(C(F)(F)F)C1
(4-bromo-2-methylpyrazol-3-yl)-[5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]methanone